Letter: ustekinumab's effectiveness compared with vedolizumab in Crohn's disease-what about mucosal healing and biomarkers? Authors' reply

Vince B. C. Biemans*, Frank Hoentjen, Marieke J. Pierik

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)753-754
Number of pages2
JournalAlimentary Pharmacology & Therapeutics
Issue number4
Publication statusPublished - Aug 2020

Cite this